SUMATRIPTAN AND NAPROXEN SODIUM
Clinical safety rating: avoid
Other 5-HT1 agonists and MAOIs can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Tablet 100 mg - Oral
Clinical note
dizziness
Loading safety data…